Page last updated: 2024-09-04

drospirenone and ethinyl estradiol combination and omeprazole

drospirenone and ethinyl estradiol combination has been researched along with omeprazole in 1 studies

Compound Research Comparison

Studies
(drospirenone and ethinyl estradiol combination)
Trials
(drospirenone and ethinyl estradiol combination)
Recent Studies (post-2010)
(drospirenone and ethinyl estradiol combination)
Studies
(omeprazole)
Trials
(omeprazole)
Recent Studies (post-2010) (omeprazole)
130511029,0852,7371,487

Protein Interaction Comparison

ProteinTaxonomydrospirenone and ethinyl estradiol combination (IC50)omeprazole (IC50)
Mcl-1Homo sapiens (human)3.1448
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.28
Potassium-transporting ATPase alpha chain 1Homo sapiens (human)1.45
Cytochrome P450 2C19Homo sapiens (human)2.315
Potassium-transporting ATPase subunit betaHomo sapiens (human)1.45
WD repeat-containing protein 5Homo sapiens (human)1.7
Glutathione S-transferase omega-1Homo sapiens (human)4.6
Histone-lysine N-methyltransferase 2AHomo sapiens (human)1.7
Muscarinic acetylcholine receptorCavia porcellus (domestic guinea pig)3.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourke, J; Roper, S1

Other Studies

1 other study(ies) available for drospirenone and ethinyl estradiol combination and omeprazole

ArticleYear
In with the new: the determinants of prescribing innovation by general practitioners in Ireland.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2012, Volume: 13, Issue:4

    Topics: Age Factors; Androstenes; Citalopram; Drug Prescriptions; Drug Utilization; Ethinyl Estradiol; General Practitioners; Humans; Information Dissemination; Insurance Claim Review; Ireland; Lactones; Loratadine; Nicotine; Omeprazole; Practice Patterns, Physicians'; Residence Characteristics; Sulfones; Therapies, Investigational; Time Factors

2012